Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Pharmaceuticals Major
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| JNJ | Johnson & Johnson | -0.26% | 170.03 | 0.7% | $1331.54m | |
| PFE | Pfizer Inc. | -2.20% | 36.49 | 0.9% | $1159.91m | |
| LLY | Eli Lilly & Co. | -2.20% | 208.05 | 1.1% | $1015.13m | |
| ABBV | AbbVie, Inc. | -3.52% | 104.98 | 1.9% | $715.83m | |
| AZN | AstraZeneca Plc | -2.43% | 53.12 | 1.2% | $688.91m | |
| MRK | Merck & Co., Inc. | -1.82% | 78.79 | 0.7% | $682.04m | |
| BMY | Bristol-Myers Squibb Co. | -2.61% | 62.76 | 1.0% | $681.69m | |
| ARCT | Arcturus Therapeutics Holdings, Inc. | 7.85% | 70.09 | 0.0% | $231.22m | |
| NVS | Novartis AG | -1.87% | 94.15 | 0.2% | $193.57m | |
| VTRS | Viatris, Inc. | 0.03% | 17.10 | 0.0% | $191.90m | |
| RPRX | Royalty Pharma Plc | -0.28% | 52.67 | 0.2% | $182.22m | |
| GSK | GlaxoSmithKline Plc | -1.41% | 38.69 | 0.2% | $160.42m | |
| GRTS | Gritstone Oncology, Inc. | -6.18% | 19.29 | 0.0% | $148.09m | |
| SNY | Sanofi | -2.35% | 48.00 | 0.2% | $133.90m | |
| TAK | Takeda Pharmaceutical Co., Ltd. | -3.14% | 17.61 | 0.0% | $82.06m |
Company Profile
Hoth Therapeutics, Inc. is a development stage biopharmaceutical company, which engages in the provision and development of therapeutic platform. The company focuses on the patients suffering from conditions such as atopic dermatitis, also known as eczema. It offers BioLexa Platform, a proprietary, patented, drug compound platform for the treatment of eczema. The company was founded by Robbie Knie, Matthew D. Eitner, and James Ahern in May 2017 and is headquartered in New York, NY.